Payments in the Event of Progenics Non-Defaulting Termination. In consideration of the direct license granted by the University to Progenics under Section 5.1.1 hereof, in the event of a Progenics Non-Defaulting Termination of the University Agreement, Progenics shall pay to the University any payments which ProNev would have been required to pay to the University under the University Agreement (had the University Agreement remained in effect) in connection with the sublicense of the University Patents and University Know-How under the Progenics-Salix Agreement at such times such payments would have otherwise become due under the University Agreement. Progenics shall be entitled to deduct any amount paid to the University under this Section 5.1.3 from any amounts that Progenics owes to ProNev under the UR Labs-Progenics Agreement.
Appears in 2 contracts
Samples: 2010 Agreement Related to Progenics’s MNTX in License (Salix Pharmaceuticals LTD), License Agreement (Progenics Pharmaceuticals Inc)
Payments in the Event of Progenics Non-Defaulting Termination. In consideration of the direct license granted by the University to Progenics under Section 5.1.1 hereof(Direct License to Progenics), in the event of a Progenics Non-Defaulting Termination of the University Agreement, Progenics shall pay to the University any payments which ProNev would have been required to pay to the University under the University Agreement (had the University Agreement remained in effect) in connection with the sublicense of the University Patents in Japan and University Know-How under the Progenics-Salix Ono Agreement at such times such payments would have otherwise become due under the University Agreement. Progenics shall be entitled to deduct any amount paid to the University under this Section 5.1.3 (Payments in the Event of Progenics Non-Defaulting Termination) from any amounts that Progenics owes to ProNev under the UR Labs-Progenics Agreement.
Appears in 1 contract
Samples: 2008 Agreement Related to Progenics’ MNTX in License (Progenics Pharmaceuticals Inc)
Payments in the Event of Progenics Non-Defaulting Termination. In consideration of the direct license granted by the University to Progenics under Section 5.1.1 hereof5.1.1, in the event of a Progenics Non-Defaulting Termination of the University Agreement, Progenics shall pay to the University any payments which ProNev would have been required to pay to the University under the University Agreement (had the University Agreement remained in effect) in connection with the sublicense of the University Patents and University Know-How under the Progenics-Salix Wyeth Agreement at such times such payments would have otherwise become due under the University Agreement. Progenics shall be entitled to deduct any amount paid to the University under this Section 5.1.3 5.1.2 from any amounts that Progenics owes to ProNev under the UR Labs-Progenics Agreement.
Appears in 1 contract
Samples: Option and License Agreement (Progenics Pharmaceuticals Inc)